iih glp-1 Exenatide (a receptor agonist) rapidly lowered intracranial pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP-lowering A Comprehensive Review of the

A prespecified analysis of pooled data from the STEP-HFpEF and STEP-HFpEF DM trials demonstrated that significantly more patients treated with Wegovy 2.4 mg SC once weekly had an improvement of at least one New York Heart Association (NYHA) functional class compared to those who received placebo (32.6% versus 21.5%, respectively

Safety & Candidacy BPC/TB-15 high-dose therapy requires careful medical evaluation to ensure appropriate candidacy

These new insights suggest that GLP-1R may be a potential target for the development of novel drugs in the treatment of OA

Prolonged UV exposure can induce matrix metalloproteinase-2 (MMP-2) and MMP-9 activation in basement membrane which can lead to collagen types 4 and 6 degradation and accumulation of more elastic fibers in melasma patients (Inomata et al., 2003)